The Israel Anti-Boycott Act (S.720 and H.R.1697), a bill in Congress attracting debate, is considered by some to protect the interests of the United States and by others to violate the First Amendment right to free speech. Regardless of how the proposed legislation pans out, it is casting a spotlight on existing U.S. anti-boycott laws and regulations that are often overlooked when structuring cross-border transactions. These laws require serious consideration.

International deals are complex and can be expensive, and they expose the parties involved to regulations both in the United States and in foreign countries. In some circumstances, merely entering into a contract with a foreign party can result in a violation of the U.S. anti-boycott laws.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]